Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...

A research team at Leibniz-HKI has described a new enzyme that renders the highly toxic molecule malleicyprol harmless.

Researchers have captured real-time "molecular movies" showing how an enzyme changes shape during catalysis. The study was ...

Tividenofusp alfa treatment showed reduction and normalization in key disease biomarkers, stabilization or improvement in clinical endpoints including adaptive behavior, cognition and hearing, and ...

Hansa Biopharma AB, ("Hansa" or "the Company"), (Nasdaq Stockholm: HNSA), today announced the submission of a Biologics License ...

Dyadic Applied BioSolutions ('Dyadic”, 'we”, 'us”, 'our”, or the 'Company”) (NASDAQ: DYAI), a global biotechnology company ...

Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...

Fluoride remains the cornerstone of preventive dentistry, and researchers have analyzed the many delivery methods of fluoride ...

High-resolution structures explain the mechanism of human PNPase and provide insights into mutations causing hereditary hearing loss and neurological disease. Researchers at the Department of Cell and ...

A group of Iranian scientists from the National Institute of Genetic Engineering and Biotechnology claimed that they have ...

The global transition to a hydrogen-based clean energy economy faces a critical bottleneck: current proton exchange membrane ...